DISORDERS OF SEXUAL
DEVELOPMENT
Dr V V A CH SEKHAR REDDY
1st YEAR DrNB
APOLLO,JUBILEE HILLS
OBJECTIVES
• INTRODUCTION
• EMBRYOLOGY, NORMAL DEVELOPMENT, PHYSIOLOGY OF SEXUAL
DEVELOPMENT.
• CLASSIFICATION OF DSD
• CONGENITAL ADRENAL HYPERPLASIA
• EVALUATION OF NEWBORN WITH AMBIGUOUS GENITALIA
• MEDICAL MANAGEMENT
• SURGICAL MANAGEMENT
1
INTRODUCTION
• 1 IN 5000 BIRTHS
• CAH AND MIXED GONADAL DYSGENESIS ARE MOST COMMON
FORMS OF DSD (50% OF CASES)
• OLD TERMINOLOGY LIKE INTERSEX, HERMAPHRODITES HAVE BEEN
REPLACED
• CAN BE AN ENDOCRINE EMERGENCY IN NEWBORNS AND
PSYCHOSOCIAL STIGMA FOR BOTH PARENTS AND GROWING CHILD
DSD
• DSD DEFINED AS ANY ATYPICAL DEVELOPMENT OF
CHROMOSOMAL/GONADAL/PHENOTYPIC SEX
• SUSPECT IF ANY ATYPICAL EXTERNAL GENITALIA, DELAYED PUBERTY,
AMENORRHOEA, INFERTILITY ETC.
• 2006 CHICAGO CONSENSUS STILL FORMS BASIS FOR MANAGEMENT
OF DSD
AMBIGUOUS GENITALIA
• AN INFANT WITH 2 OR MORE OF
1. CRYPTORCHIDISM
2. HYPOSPADIAS
3. MICROPHALLUS <2.5CM OR CLITOROMEGALY >1CM
2
EMBRYOLOGY
NORMAL DEVELOPMENT
PHYSIOLOGY OF SEXUAL DEVELOPMENT
STERIOD HORMONE SYNTHESIS PHYSIOLOGY
FERTILIZATION
CHROMOSOMAL
SEX
GONADAL SEX HORMONAL SEX PHENOTYPIC SEX
20 WEEKS OF
GESTATION
MALE FEMALE
CHROMOSOMAL SEX 46XY 46XX
GONADAL SEX (6 WEEKS OF
GESTATION
BIPOTENTIAL GONAD WILL
BECOME TESTIS IN THE PRESENCE
OF SRY GENE
BIPOTENTIAL GONAD WILL
BECOME OVERY IN THE ABSENCE
OF SRY GENE
HORMONAL SEX SERTOLI CELLS -> AMH -> WOLFIAN
DUCT DEVELOPS INTO MALE
INTERNAL GENITALIA
LEYDIG CELLS -> TESTOSTERONE ->
MALE EXTERNAL GENITALIA
NO AMH & TESTOSTERONE ->
WOLFFIAN DUCT REGRESS,
MULLERIAN DUCT DEVELOPS INTO
FEMNALE INTERNAL AND
EXTERNAL GENITALIA
PHENOTYPIC SEX MALE FETUS FEMALE FETUS
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
3
CLASSIFICATION OF DSD
NOMENCLATURE
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
1.DISORDERS OF GONDAL DIFFERENTIATION
KLINFELTER SYNDROME – 46XXY MALE
TURNER SYNDROME – 46X0 FEMALE
46XX MALE
PURE GONDAL DYSGENESIS
MIXED GONADAL DYSGENESIS
PARTIAL GONADAL DYSGENESIS
BILATERAL VANISHING TESTIS AND EMBRYONIC TESTICULAR
REGRESSION SYNDROME
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
46XX MALE
• MALE PHENOTYPE WITH NORMAL SKELETAL ARCHITECTURE
COMPARED TO KLINFELTER
• ALL ARE INFEERTILE
• DUE TO TRANSLOCATION OF SRY GENE OF Y TO X CHROMOSOME.
• NEEDS ANDROGENS FOR ATTAINING PUBERTY AND SECONDARY
SEXUAL CHARACTERISTICS
PURE GONADAL DYSGENESIS – 46 XX
• 46XX WITH NORMAL FEMALE DEVELOPMENT WITH STREAK OVARIES
WITH LACK OF SECONDARY SEXUAL CHARACTERSTICS
• COMPARED WITH TURNER SYNDOME, NO SOMATIC FEATURES EXIST
• TREATMENT IS REPLACEMENT OF SEX STEROIDS
PURE GONADAL DYSGENESIS – 46 XY(SWYER
SYNDROME)
• NORMAL FEMALE WITH MULLERIAN STRUCTURES WITH STREAK
GONADS
• PRESENT IN THEIR TEENS WITH DELAYED PUBERTY WITH
AMENORRHOEA
• ELEVATED GONADOTROPIN LEVELS GIVES THE CLUE
• SIGNIFICANT RISK OF DEVELOPING GERM CELL TUMORS
(GONADOBLASTOMA)
• B/L GONADECTOMY WITH ESTROGEN AND PROGESTRONE THERAPY
IS THE TREATMENT
MIXED GONADAL DYSGENESIS
• UNILATERAL UNDESCENDED TESTIS WITH OPPOSITE STREAK OVARY
WITH PERSISTENT MULLERIAN STRUCTURES AND FEATURES OF
MASCULIZATION
• 45X0/46XY
• 2ND MOST COMMON CAUSE OF AMBIGUOUS GENITALIA AFTER CAH
• INCREASED RISK FOR GERM CELL TUMORS AND WILMS
TUMOR(DENYS DRASH SYNDROME)
• TREATMENT CONSISTS OF GENDER ASSIGNMENT, GONADECTOMY,
SCREENING FOR WILMS.
PARTIAL GONADAL DYSGENESIS
• SIMILAR TO MIXED GONADAL DYSGENESIS BUT WITH TWO
DYSGENTIC TESTIS
• VARYING DEGREES OF AMH AND TESTOSTERONE PRODUCTION LEAD
TO VARIED DEVELOPMENT OF MULLERIAN STRUCTURES
• INCREASED RISK FOR GERM CELL TUMORS
• TREATMENT IS SIMILAR TO MIXED GONADAL DYSGENESIS
B/L VANISHING TESTIS SYNDROME AND
EMBRYONIC TESTICULAR REGRESSION
• 46 XY WITH ABSENT TESTIS WITH EVIDENCE OF TESTICULAR
FUNCTION AT SOME POINT OF DEVELOPMENT
• DUE TO GENETIC MUTATION/TERATOGEN/BILATERAL TORSION
• EMBRYONIC TESTICULAR REGRESSION A/W AMBIGUOUS GENITALIA
WHEREAS B/L VANISHING TESTIS A/W NORMAL MALE WITH EMPTY
SCROTUM, MICROPHALLUS.
• LOW TESTOSTERONE WITH ELEVATED GONADOTROPINS WITH BLIND
ENDING VAS DURING LAPAROSCOPY.
2.OVOTESTICULAR DSD(TRUE
HERMAPHRODITISM)
• HAVING BOTH TESTIS AND OVARY WITH 46XX/46XY
• PRESENTED WITH AMBIGUOUS EXTERNAL GENITALIA WITH VARIED
DEVELOPMENT OF INTERNAL STRUCTURES
• MOST OF THE TIMES PRESENT AS MALE WITH HYPOSPADIAS AND
CHORDEE
• OVARY IF PRESENT ON LEFT SIDE AND TESTIS WILL BE USUALLY ON RIGHT
SIDE ANYWHERE ALONG ITS PATH OF DESCENT AND MOSTLY DYSGENETIC
• GONADS DISCOVERED IN LABIOSCRIOTAL FOLD/INGUINAL CANAL MOSTLY
WILL BE OVOTESTIS AND DIFFERNCE IN FIRMNESS IN THE POLAR REGION.
• RAISED AS FEMALE BECAUSE OVARY IS FUNCTIONAL MOST OF THE TIMES
3.46XX DSD ( MASCULINISED FEMALE)
• MOST CAMMON CAUSE OF AMBIGUOUS GENITALIA AND IS DUE TO
CAH
• RARELY CAUSED BY MATERNAL ANDROGEN SUPPLEMENT/VIRILIZING
TUMORS IN MOTHER
• 95% OF CASES OF CAH ARE DUE TO 21 HYDROXYLASE DEFECIENCY
AND 5% DUE TO 11 β HYDROXYLASE DEFECIENCY
5
CONGENITAL ADRENAL HYPERPLASIA
HAVING MINERALO
CORTICOID PROPERTY
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
21 HYDROXYLASE DEFECIENCY
• DIVIDED INTO 3 CATEGORIES
1. SALT WASTERS
2. SIMPLE VIRILIZERS
3. NONCLASSIC
• 75% ARE SALT WASTERS AND 25% ARE VIRILIZERS
• NEONATAL SCREENING WITH 17 HYDROXY PROGESTERONE IS VALUABLE
TOOL
• IN BETWEEN 1ST AND 2ND WEEKS PRESENTS WITH SYMPTOMS LIKE FAILURE
TO THRIVE, FAILURE TO GAIN WEIGHT,VOMITINGS, DEHYDRATION MAY
MIMIC PYLORIC STENOSIS/SEPSIS.
• MALES LOOKS LIKE LITTLE HERCULES WITH PRECOCIOUS PUBERTY WITH
SHORT STATURE AND INFERTILITY( DUE TO TESTICULAR ADRENAL REST
TISSUE)
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
4.46XY DSD ( UNDERMASCULINISED MALE)
• LEYDIG CELL APLASIA(LH RECEPTOR ABNORMALITY)
• DISORDERS OF TESTOSTERONE BIOSYNTHESIS
• ANDROGEN RECEPTOR AND POSTRECEPTOR DEFECTS
• 5 α REDUCTASE DEFECIENCY
• PERSISTENT MULLERIAN DUCT SYNDROME
LEYDIG CELL APLASIA(LH RECEPTOR
ABNORMALITY)
• 46XY WITH FEMALE PHENOTYPE WITH TESTIS PALPABLE IN INGUINAL
CANAL OR LABIA WITHOUT ANY MULLERIAN STRUCTURES
• DELAYED PUBERTY WITH NO SECONDARY SEXUAL CHARECTERISTICS
WITH ABSENCE OF RAISE IN SERUM TESTOSTERONE AFTER HCG
STIMULATION IS THE HALLMARK
DISORDERS OF TESTOSTERONE BIOSYNTHESIS
STAR(STEROIDOGENIC ACUTE REGULATORY
PROTEIN) DEFECIENCY – CONGENITAL LIPOID
ADRENAL HYPERPLASIA
• DUE TO DEFECT IN CHOLESTEROL TRANSPORT INTO ADRENAL CELL
• NEONATE, NON VIRILIZED FEMALE WITH ACUTE ADRENAL
INSUFFICIENCY WITH CT S/O LARGE LIPID LADEN ADRENAL GLANDS
ARE THE HALLMARK FEATURES.
3β HSD DEFECIENCY
• SIMILAR TO STAR DEFECIENCY WITH VARYING DEGREES OF
MASCULIZATIONDUE TO PARTIAL ACTIVITY OF ENZYME.
• TREATMENT IS LIKE 21 HYDROXYLASE DEFECIENCY
17 α HYDROXYLASE DEFECIENCY
• UNDERVIRILISED MALE WITH HYPERALDOSTERONISM i.e. HTN, SALT
AND WATER RETENTION WITH HYPOKALEMIA
• TREATMENT WITH ADMINISTRATION OF GLUCOCORTICOIDS WITH
TESTOSTERONE
17,20 LYASE DEFECIENCY
• UNDERVIRILIZED OR FEMALE LOOKING MALE WITH AMBIGUOUS
GENITALIA WITH ABSENT MULLERIAN STRUCTURES WITH NORMAL
MINERALOCORTICOIDS AND GLUCOCORTCOIDS
17 β HSD DEFECIENCY
• AT BIRTH FEMALE PHENOTYPE WITHOUT VIRILIZATION AND AT
PUBERTY WILL DEVELOP MALE SECONDARY SEXUAL CHARECTERISTICS
WITH PHALLIC GROWTH PROBABLY DUE TO ACTION OF
ANDROSTENEDIONE(GENDER REVERSAL ALSO SEEN IN 5 ALFA
REDUCTASE DEFECIENCY)
• GENDER ASSIGNMENT IS CRUCIAL AT PUBERTY AND MAINLY
DEPENDS ON PATIENT AND PARENTS PREFERENCE.
ANDROGEN RECEPTOR AND POSTRECEPTOR
DEFECTS
• UNDERVIRILIZED 46 XY MALES WITH COMPLETE EXTERNAL
FEMINIZATION(CAIS) TO AMBIGUOUS GENITALIA(PAIS) WITH
INFERTILITY WITH NO MULLERIAN DERIVATIVES
COMPLETE ANDROGEN INSENSITIVITY
SYNDROME
• 46 XY WITH BOTH TESTIS, FEMALE EXTERNAL GENITALIA WITH NO
MULLERIAN DERIVATIVES AND FEMALE SECONDARY SEXUAL
CHARACTERISTICS DUE TO AROMATIZATION OF TESTOSTERONE WITH
SPARSE PUBIC AND AXILLARY HAIR
• PATIETNS PRESENT WITH AMENORRHOEA WITH NO PUBIC HAIR
WITH BOTH TESTIS IN INGUINAL AREA
• GONADECTOMY DELAYED UNTIL PUBERTY BECAUSE TESTIS IS SOURCE
OF ESTROGEN AND MALIGNANCY RISK IS LOW.
PARTIAL ANDROGEN INSENSITIVITY
SYNDROME
• X LINKED DISORDER WITH VARYING DEGREES OF
PRESENTATION WITH AMBIGUOUS GENITALIA
• MANAGEMENT IS INDIVIDUALIZED
5 α REDUCTASE DEFECIENCY
• 46XY WITH AMBIGUOUS GENITALIA OR FEMALE PRESENTATION WITH
NORMAL WOLFFIAN STRUCTURES AND ABSENT MULLERIAN
DERIVATIVES AND AT PUBERTY MALE SECONDARY SEXUAL
CHARECTERISTICS WILL DEVELOP(GENDER REVERSAL ALSO SEEN IN
17 β HSD DEFECIENCY)
• ELEVATED T WITH LOW DHT IS THE HALLMARK.
• GENDER ASSIGNMENT IS AGAIN TO BE DISCUSSED WITH PATIENT
AND FAMILY
PERSISTENT MULLERIAN DUCT
SYNDROME(HERNIA UTERI INGUINALE)
• 46XY WITH NORMAL MALE EXTERNAL GENITALIA WITH INTERNAL
MULLERIAN DERIVATIVES WITH VAGINA DRAINING INTO PROSTATIC
UTRICLE.
• DUE TO MUTATIONS IN AMH GENE
• ORCHIDOPEXY IS THE TREATMENT
• SHOUD NOT DISTRUB MULLERIAN STRUCTURES BECAUSE OF CLOSE
VICINITY TO VAS DEFERENS
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
5.UNCLASSIFIED – MAYER ROKITANSKY
KUSTER HAUSER SYNDROME
• 46 XX WITH NORMAL FEMALE WITH SECONDARY SEXUAL
CHARACTERISTICS AND NORMAL EXTERNAL GENITALIA WITH ABSENT
UTERUS AND UPPER PART OF VAGINA
• PRESENTED WITH PRIMARY AMENORRHOEA
• ASSOCIATED URINARY TRACT ANAMOLIES LIKE RENAL AGENESIS,
HORSE SHOE KIDNEY AND PELVIC KIDNEY CAN OCCUR.
4
EVALUATION OF NEWBORN WITH
AMBIGUOUS GENITALIA
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
6
MEDICAL MANAGEMENT
HISTORY
• FULL NEWBORN HISTORY (PRENATAL, PREGNANCY AND BIRTH HISTORIES)
• ANY MATERNAL VIRILIZATION DURING THE PREGNANCY: ACNE, HIRSUTISM,
FRONTAL BALDING, VOICE DEEPENING OR CLITOROMEGALY
• MATERNAL HORMONAL DISORDERS
• PRENATAL DRUG USE
• CONSANGUINITY
• DETAILED FAMILY HISTORY LIKE ANY UNEXPLAINED NEONATAL DEATH,
AMBIGUOUS GENITALIA, ABNORMAL PUBERTY, INFERTILITY OR
AMENORRHEA
PHYSICAL EXAMINATION
• VITALS (INCLUDING BLOOD PRESSURE), WEIGHT, LENGTH, HEAD
CIRCUMFERENCE
• INSPECT FOR DEVELOPMENTAL ABNORMALITIES CONSISTENT WITH A
POSSIBLE SYNDROME
• INSPECT FOR SKIN TURGOR AND HYPERPIGMENTATION
• DOCUMENT THE NUMBER AND LOCATION OF UROGENITAL OPENINGS
• PALPATE LABIOSCROTAL FOLDS AND INGUINAL REGION FOR GONADS
• INSPECT LABIOSCROTAL FOLDS FOR ASYMMETRY, MASCULINIZATION,
SWELLING, PIGMENTATION, FUSION AND CREASES
• INSPECT PENIS FOR HYPOSPADIAS, URETHRAL DEFECTS, OR CHORDEE
• MEASURE PHALLIC LENGTH; MEASURE CLITORAL LENGTH
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT
NVESTIGATIONS
• KARYOTYPING AND RAPID ANEUPLOIDY TEST
• USG ABDOMEN AND PELVIS WITH INGUINAL REGION
• SERUM 17-HYDROXYPROGESTERONE LEVEL
• SERUM SODIUM, POTASSIUM, RENIN LEVELS
• SERUM AMH, TESTOSTERONE, LH, FSH, CORTISOL LEVELS
TREATMENT
• INVOLVES MULTIDISCIPLINARY TEAM OF ENDOCRINOLOGIST,
PEDIATRICIAN, UROLOGIST, GYNECOLOGIST, PSYCHOLOGIST
• DEPENDS MAINLY ON THE DIAGNOSIS
• 3 MOST COMMONLY FOUND DIAGNOSES ARE CAH,MIXED GONADAL
DYSGENESIS, ANDROGEN INSENSITIVITY SYNDROME.
TRRATMENT OF CAH
• IN SALT WASTING 21-HYDROXYLASE DEFECIENCY CAH START WITH
HYDROCORTISONE, FLUDROCORTISONE
• PRENATAL DEXAMETHASONE TO MOTHER F/B CHORIONIC VILLLOUS
SAMPLING TO DETERMINE SEX AT 12-14 WEEEKS ADVISED IN
CARRIERS OR H/O CAH IN MOTHER.
CERNOS DEPOT
7
SURGICAL MANAGEMENT
• FEMINISING GENITOPLASTY
• MASCULINISING GENITOPLASTY
• LAPAROSCOPY
FEMINISING GENITOPLASTY
• CREATION OF FEMALE LOOKING LABIA MAJORA, MINORA WITH
INTROITUS
• INVERTED V-Y VAGINOPLASTY F/B VAGINAL DILATATIONS TO PROVIDE
ADEQUATE FUNCTIONAL VAGINA OPENING INTO INTROITUS
• REDUCTION CLITOROPLASTY WITH REDUCTION OF ERECTILE TISSUE
i.e. REDUCTION OF PHALLUS WITH PRESERVATION OF GLANS AND ITS
NEUROVASCULAR SUPPLY WITH CLITORAL HOOD
MASCULINISING GENITOPLASTY
• REPAIR HYPOSPADIAS WITH CORRECTION OF CHORDEE
• ORCHIDOPEXY
• SCROTAL TRANSPOSITION i.e. CORRECT BIFID SCROTUM AND
PREPENILE POSITION OF SCROTUM
• SEPARATE MULLERIAN STRUCTURES FROM URETHRA
• EXCISE IF ANY GONADAL TISSUE WHICH IS AT RISK OF MALIGNANCY
LAPAROSCOPY
• INDICATIONS
1. TO DIAGNOSE INTRAABDOMINAL ANATOMY WHEN IN DOUBT
2. BIOPSY/EXCISION OF DYSPLASTIC GONADS CONTAINING Y CHROMOSOME
3. EXCISION OF INTERNAL GENITALIA IF NOT REQUIRED FOR ASSIGNED
GENDER
4. DIGNOSIS OF COMPLEX CLOACAL ANAMOLIES
DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT

More Related Content

PPTX
APPROACH TO A CHILD hehehehWITH DSD.pptx
PPTX
Sexual deveolpment disorders.pptx
PPTX
INTERSEX SLIDES 2-134556788843322344.pptx
PPTX
Approach to dsd siddarth mahajan
PPTX
Ambiguous Genitalia
PPTX
Disorders Sex Development
PPTX
Ambiguous gentalia
PPTX
Intersex presentation
APPROACH TO A CHILD hehehehWITH DSD.pptx
Sexual deveolpment disorders.pptx
INTERSEX SLIDES 2-134556788843322344.pptx
Approach to dsd siddarth mahajan
Ambiguous Genitalia
Disorders Sex Development
Ambiguous gentalia
Intersex presentation

Similar to DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT (20)

PPTX
Ambiguous genitalia
PPTX
AMBIGUOUS GENITALIA1234567890088997778.pptx
PPTX
Dsd update
PPTX
DSD oshiba
PPTX
Seminar on DSD
PPTX
dsd 1.pptx
PPTX
Ambiguous genitalia
PPTX
Disorders of sex development.pptx
PPTX
Disorders of sex development
PDF
ambiguous genitalia
PPTX
Disorder of Sex Differentiattion ( ambiguos genitelia )
PPT
Gynecology 5th year, 3rd lecture (Dr. Maryam)
PPTX
Approach to DSD (Ambiguous genitalia)
PPTX
Disorders of sexual differentiation
PPSX
PPTX
Approach to a case of ambiguous genitalia
PPTX
DOC-20240129-WA00vbhbxb bbxbhdhdime13..pptx
PPT
Management Disorder of Sexual Development(DSD)
PPTX
DSD ( disorders of sexual development).pptx
Ambiguous genitalia
AMBIGUOUS GENITALIA1234567890088997778.pptx
Dsd update
DSD oshiba
Seminar on DSD
dsd 1.pptx
Ambiguous genitalia
Disorders of sex development.pptx
Disorders of sex development
ambiguous genitalia
Disorder of Sex Differentiattion ( ambiguos genitelia )
Gynecology 5th year, 3rd lecture (Dr. Maryam)
Approach to DSD (Ambiguous genitalia)
Disorders of sexual differentiation
Approach to a case of ambiguous genitalia
DOC-20240129-WA00vbhbxb bbxbhdhdime13..pptx
Management Disorder of Sexual Development(DSD)
DSD ( disorders of sexual development).pptx
Ad

Recently uploaded (20)

PDF
medical_surgical_nursing_10th_edition_ignatavicius_TEST_BANK_pdf.pdf
PDF
IGGE1 Understanding the Self1234567891011
PDF
AI-driven educational solutions for real-life interventions in the Philippine...
PPTX
Introduction to pro and eukaryotes and differences.pptx
PDF
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
PDF
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 2).pdf
PDF
Empowerment Technology for Senior High School Guide
PDF
Complications of Minimal Access-Surgery.pdf
PDF
Τίμαιος είναι φιλοσοφικός διάλογος του Πλάτωνα
PDF
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
PDF
International_Financial_Reporting_Standa.pdf
PDF
MBA _Common_ 2nd year Syllabus _2021-22_.pdf
PPTX
Share_Module_2_Power_conflict_and_negotiation.pptx
PDF
David L Page_DCI Research Study Journey_how Methodology can inform one's prac...
PDF
What if we spent less time fighting change, and more time building what’s rig...
PDF
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 1)
PDF
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
PDF
ChatGPT for Dummies - Pam Baker Ccesa007.pdf
PPTX
Onco Emergencies - Spinal cord compression Superior vena cava syndrome Febr...
PDF
1.3 FINAL REVISED K-10 PE and Health CG 2023 Grades 4-10 (1).pdf
medical_surgical_nursing_10th_edition_ignatavicius_TEST_BANK_pdf.pdf
IGGE1 Understanding the Self1234567891011
AI-driven educational solutions for real-life interventions in the Philippine...
Introduction to pro and eukaryotes and differences.pptx
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 2).pdf
Empowerment Technology for Senior High School Guide
Complications of Minimal Access-Surgery.pdf
Τίμαιος είναι φιλοσοφικός διάλογος του Πλάτωνα
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
International_Financial_Reporting_Standa.pdf
MBA _Common_ 2nd year Syllabus _2021-22_.pdf
Share_Module_2_Power_conflict_and_negotiation.pptx
David L Page_DCI Research Study Journey_how Methodology can inform one's prac...
What if we spent less time fighting change, and more time building what’s rig...
BP 704 T. NOVEL DRUG DELIVERY SYSTEMS (UNIT 1)
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
ChatGPT for Dummies - Pam Baker Ccesa007.pdf
Onco Emergencies - Spinal cord compression Superior vena cava syndrome Febr...
1.3 FINAL REVISED K-10 PE and Health CG 2023 Grades 4-10 (1).pdf
Ad

DISORDERS OF SEXUAL DEVELOPMENT BASICS.PPT

  • 1. DISORDERS OF SEXUAL DEVELOPMENT Dr V V A CH SEKHAR REDDY 1st YEAR DrNB APOLLO,JUBILEE HILLS
  • 2. OBJECTIVES • INTRODUCTION • EMBRYOLOGY, NORMAL DEVELOPMENT, PHYSIOLOGY OF SEXUAL DEVELOPMENT. • CLASSIFICATION OF DSD • CONGENITAL ADRENAL HYPERPLASIA • EVALUATION OF NEWBORN WITH AMBIGUOUS GENITALIA • MEDICAL MANAGEMENT • SURGICAL MANAGEMENT
  • 4. • 1 IN 5000 BIRTHS • CAH AND MIXED GONADAL DYSGENESIS ARE MOST COMMON FORMS OF DSD (50% OF CASES) • OLD TERMINOLOGY LIKE INTERSEX, HERMAPHRODITES HAVE BEEN REPLACED • CAN BE AN ENDOCRINE EMERGENCY IN NEWBORNS AND PSYCHOSOCIAL STIGMA FOR BOTH PARENTS AND GROWING CHILD
  • 5. DSD • DSD DEFINED AS ANY ATYPICAL DEVELOPMENT OF CHROMOSOMAL/GONADAL/PHENOTYPIC SEX • SUSPECT IF ANY ATYPICAL EXTERNAL GENITALIA, DELAYED PUBERTY, AMENORRHOEA, INFERTILITY ETC. • 2006 CHICAGO CONSENSUS STILL FORMS BASIS FOR MANAGEMENT OF DSD
  • 6. AMBIGUOUS GENITALIA • AN INFANT WITH 2 OR MORE OF 1. CRYPTORCHIDISM 2. HYPOSPADIAS 3. MICROPHALLUS <2.5CM OR CLITOROMEGALY >1CM
  • 7. 2 EMBRYOLOGY NORMAL DEVELOPMENT PHYSIOLOGY OF SEXUAL DEVELOPMENT STERIOD HORMONE SYNTHESIS PHYSIOLOGY
  • 8. FERTILIZATION CHROMOSOMAL SEX GONADAL SEX HORMONAL SEX PHENOTYPIC SEX 20 WEEKS OF GESTATION
  • 9. MALE FEMALE CHROMOSOMAL SEX 46XY 46XX GONADAL SEX (6 WEEKS OF GESTATION BIPOTENTIAL GONAD WILL BECOME TESTIS IN THE PRESENCE OF SRY GENE BIPOTENTIAL GONAD WILL BECOME OVERY IN THE ABSENCE OF SRY GENE HORMONAL SEX SERTOLI CELLS -> AMH -> WOLFIAN DUCT DEVELOPS INTO MALE INTERNAL GENITALIA LEYDIG CELLS -> TESTOSTERONE -> MALE EXTERNAL GENITALIA NO AMH & TESTOSTERONE -> WOLFFIAN DUCT REGRESS, MULLERIAN DUCT DEVELOPS INTO FEMNALE INTERNAL AND EXTERNAL GENITALIA PHENOTYPIC SEX MALE FETUS FEMALE FETUS
  • 18. 1.DISORDERS OF GONDAL DIFFERENTIATION KLINFELTER SYNDROME – 46XXY MALE TURNER SYNDROME – 46X0 FEMALE 46XX MALE PURE GONDAL DYSGENESIS MIXED GONADAL DYSGENESIS PARTIAL GONADAL DYSGENESIS BILATERAL VANISHING TESTIS AND EMBRYONIC TESTICULAR REGRESSION SYNDROME
  • 21. 46XX MALE • MALE PHENOTYPE WITH NORMAL SKELETAL ARCHITECTURE COMPARED TO KLINFELTER • ALL ARE INFEERTILE • DUE TO TRANSLOCATION OF SRY GENE OF Y TO X CHROMOSOME. • NEEDS ANDROGENS FOR ATTAINING PUBERTY AND SECONDARY SEXUAL CHARACTERISTICS
  • 22. PURE GONADAL DYSGENESIS – 46 XX • 46XX WITH NORMAL FEMALE DEVELOPMENT WITH STREAK OVARIES WITH LACK OF SECONDARY SEXUAL CHARACTERSTICS • COMPARED WITH TURNER SYNDOME, NO SOMATIC FEATURES EXIST • TREATMENT IS REPLACEMENT OF SEX STEROIDS
  • 23. PURE GONADAL DYSGENESIS – 46 XY(SWYER SYNDROME) • NORMAL FEMALE WITH MULLERIAN STRUCTURES WITH STREAK GONADS • PRESENT IN THEIR TEENS WITH DELAYED PUBERTY WITH AMENORRHOEA • ELEVATED GONADOTROPIN LEVELS GIVES THE CLUE • SIGNIFICANT RISK OF DEVELOPING GERM CELL TUMORS (GONADOBLASTOMA) • B/L GONADECTOMY WITH ESTROGEN AND PROGESTRONE THERAPY IS THE TREATMENT
  • 24. MIXED GONADAL DYSGENESIS • UNILATERAL UNDESCENDED TESTIS WITH OPPOSITE STREAK OVARY WITH PERSISTENT MULLERIAN STRUCTURES AND FEATURES OF MASCULIZATION • 45X0/46XY • 2ND MOST COMMON CAUSE OF AMBIGUOUS GENITALIA AFTER CAH • INCREASED RISK FOR GERM CELL TUMORS AND WILMS TUMOR(DENYS DRASH SYNDROME) • TREATMENT CONSISTS OF GENDER ASSIGNMENT, GONADECTOMY, SCREENING FOR WILMS.
  • 25. PARTIAL GONADAL DYSGENESIS • SIMILAR TO MIXED GONADAL DYSGENESIS BUT WITH TWO DYSGENTIC TESTIS • VARYING DEGREES OF AMH AND TESTOSTERONE PRODUCTION LEAD TO VARIED DEVELOPMENT OF MULLERIAN STRUCTURES • INCREASED RISK FOR GERM CELL TUMORS • TREATMENT IS SIMILAR TO MIXED GONADAL DYSGENESIS
  • 26. B/L VANISHING TESTIS SYNDROME AND EMBRYONIC TESTICULAR REGRESSION • 46 XY WITH ABSENT TESTIS WITH EVIDENCE OF TESTICULAR FUNCTION AT SOME POINT OF DEVELOPMENT • DUE TO GENETIC MUTATION/TERATOGEN/BILATERAL TORSION • EMBRYONIC TESTICULAR REGRESSION A/W AMBIGUOUS GENITALIA WHEREAS B/L VANISHING TESTIS A/W NORMAL MALE WITH EMPTY SCROTUM, MICROPHALLUS. • LOW TESTOSTERONE WITH ELEVATED GONADOTROPINS WITH BLIND ENDING VAS DURING LAPAROSCOPY.
  • 27. 2.OVOTESTICULAR DSD(TRUE HERMAPHRODITISM) • HAVING BOTH TESTIS AND OVARY WITH 46XX/46XY • PRESENTED WITH AMBIGUOUS EXTERNAL GENITALIA WITH VARIED DEVELOPMENT OF INTERNAL STRUCTURES • MOST OF THE TIMES PRESENT AS MALE WITH HYPOSPADIAS AND CHORDEE • OVARY IF PRESENT ON LEFT SIDE AND TESTIS WILL BE USUALLY ON RIGHT SIDE ANYWHERE ALONG ITS PATH OF DESCENT AND MOSTLY DYSGENETIC • GONADS DISCOVERED IN LABIOSCRIOTAL FOLD/INGUINAL CANAL MOSTLY WILL BE OVOTESTIS AND DIFFERNCE IN FIRMNESS IN THE POLAR REGION. • RAISED AS FEMALE BECAUSE OVARY IS FUNCTIONAL MOST OF THE TIMES
  • 28. 3.46XX DSD ( MASCULINISED FEMALE) • MOST CAMMON CAUSE OF AMBIGUOUS GENITALIA AND IS DUE TO CAH • RARELY CAUSED BY MATERNAL ANDROGEN SUPPLEMENT/VIRILIZING TUMORS IN MOTHER • 95% OF CASES OF CAH ARE DUE TO 21 HYDROXYLASE DEFECIENCY AND 5% DUE TO 11 β HYDROXYLASE DEFECIENCY
  • 32. 21 HYDROXYLASE DEFECIENCY • DIVIDED INTO 3 CATEGORIES 1. SALT WASTERS 2. SIMPLE VIRILIZERS 3. NONCLASSIC • 75% ARE SALT WASTERS AND 25% ARE VIRILIZERS • NEONATAL SCREENING WITH 17 HYDROXY PROGESTERONE IS VALUABLE TOOL • IN BETWEEN 1ST AND 2ND WEEKS PRESENTS WITH SYMPTOMS LIKE FAILURE TO THRIVE, FAILURE TO GAIN WEIGHT,VOMITINGS, DEHYDRATION MAY MIMIC PYLORIC STENOSIS/SEPSIS. • MALES LOOKS LIKE LITTLE HERCULES WITH PRECOCIOUS PUBERTY WITH SHORT STATURE AND INFERTILITY( DUE TO TESTICULAR ADRENAL REST TISSUE)
  • 35. 4.46XY DSD ( UNDERMASCULINISED MALE) • LEYDIG CELL APLASIA(LH RECEPTOR ABNORMALITY) • DISORDERS OF TESTOSTERONE BIOSYNTHESIS • ANDROGEN RECEPTOR AND POSTRECEPTOR DEFECTS • 5 α REDUCTASE DEFECIENCY • PERSISTENT MULLERIAN DUCT SYNDROME
  • 36. LEYDIG CELL APLASIA(LH RECEPTOR ABNORMALITY) • 46XY WITH FEMALE PHENOTYPE WITH TESTIS PALPABLE IN INGUINAL CANAL OR LABIA WITHOUT ANY MULLERIAN STRUCTURES • DELAYED PUBERTY WITH NO SECONDARY SEXUAL CHARECTERISTICS WITH ABSENCE OF RAISE IN SERUM TESTOSTERONE AFTER HCG STIMULATION IS THE HALLMARK
  • 38. STAR(STEROIDOGENIC ACUTE REGULATORY PROTEIN) DEFECIENCY – CONGENITAL LIPOID ADRENAL HYPERPLASIA • DUE TO DEFECT IN CHOLESTEROL TRANSPORT INTO ADRENAL CELL • NEONATE, NON VIRILIZED FEMALE WITH ACUTE ADRENAL INSUFFICIENCY WITH CT S/O LARGE LIPID LADEN ADRENAL GLANDS ARE THE HALLMARK FEATURES.
  • 39. 3β HSD DEFECIENCY • SIMILAR TO STAR DEFECIENCY WITH VARYING DEGREES OF MASCULIZATIONDUE TO PARTIAL ACTIVITY OF ENZYME. • TREATMENT IS LIKE 21 HYDROXYLASE DEFECIENCY
  • 40. 17 α HYDROXYLASE DEFECIENCY • UNDERVIRILISED MALE WITH HYPERALDOSTERONISM i.e. HTN, SALT AND WATER RETENTION WITH HYPOKALEMIA • TREATMENT WITH ADMINISTRATION OF GLUCOCORTICOIDS WITH TESTOSTERONE
  • 41. 17,20 LYASE DEFECIENCY • UNDERVIRILIZED OR FEMALE LOOKING MALE WITH AMBIGUOUS GENITALIA WITH ABSENT MULLERIAN STRUCTURES WITH NORMAL MINERALOCORTICOIDS AND GLUCOCORTCOIDS
  • 42. 17 β HSD DEFECIENCY • AT BIRTH FEMALE PHENOTYPE WITHOUT VIRILIZATION AND AT PUBERTY WILL DEVELOP MALE SECONDARY SEXUAL CHARECTERISTICS WITH PHALLIC GROWTH PROBABLY DUE TO ACTION OF ANDROSTENEDIONE(GENDER REVERSAL ALSO SEEN IN 5 ALFA REDUCTASE DEFECIENCY) • GENDER ASSIGNMENT IS CRUCIAL AT PUBERTY AND MAINLY DEPENDS ON PATIENT AND PARENTS PREFERENCE.
  • 43. ANDROGEN RECEPTOR AND POSTRECEPTOR DEFECTS • UNDERVIRILIZED 46 XY MALES WITH COMPLETE EXTERNAL FEMINIZATION(CAIS) TO AMBIGUOUS GENITALIA(PAIS) WITH INFERTILITY WITH NO MULLERIAN DERIVATIVES
  • 44. COMPLETE ANDROGEN INSENSITIVITY SYNDROME • 46 XY WITH BOTH TESTIS, FEMALE EXTERNAL GENITALIA WITH NO MULLERIAN DERIVATIVES AND FEMALE SECONDARY SEXUAL CHARACTERISTICS DUE TO AROMATIZATION OF TESTOSTERONE WITH SPARSE PUBIC AND AXILLARY HAIR • PATIETNS PRESENT WITH AMENORRHOEA WITH NO PUBIC HAIR WITH BOTH TESTIS IN INGUINAL AREA • GONADECTOMY DELAYED UNTIL PUBERTY BECAUSE TESTIS IS SOURCE OF ESTROGEN AND MALIGNANCY RISK IS LOW.
  • 45. PARTIAL ANDROGEN INSENSITIVITY SYNDROME • X LINKED DISORDER WITH VARYING DEGREES OF PRESENTATION WITH AMBIGUOUS GENITALIA • MANAGEMENT IS INDIVIDUALIZED
  • 46. 5 α REDUCTASE DEFECIENCY • 46XY WITH AMBIGUOUS GENITALIA OR FEMALE PRESENTATION WITH NORMAL WOLFFIAN STRUCTURES AND ABSENT MULLERIAN DERIVATIVES AND AT PUBERTY MALE SECONDARY SEXUAL CHARECTERISTICS WILL DEVELOP(GENDER REVERSAL ALSO SEEN IN 17 β HSD DEFECIENCY) • ELEVATED T WITH LOW DHT IS THE HALLMARK. • GENDER ASSIGNMENT IS AGAIN TO BE DISCUSSED WITH PATIENT AND FAMILY
  • 47. PERSISTENT MULLERIAN DUCT SYNDROME(HERNIA UTERI INGUINALE) • 46XY WITH NORMAL MALE EXTERNAL GENITALIA WITH INTERNAL MULLERIAN DERIVATIVES WITH VAGINA DRAINING INTO PROSTATIC UTRICLE. • DUE TO MUTATIONS IN AMH GENE • ORCHIDOPEXY IS THE TREATMENT • SHOUD NOT DISTRUB MULLERIAN STRUCTURES BECAUSE OF CLOSE VICINITY TO VAS DEFERENS
  • 49. 5.UNCLASSIFIED – MAYER ROKITANSKY KUSTER HAUSER SYNDROME • 46 XX WITH NORMAL FEMALE WITH SECONDARY SEXUAL CHARACTERISTICS AND NORMAL EXTERNAL GENITALIA WITH ABSENT UTERUS AND UPPER PART OF VAGINA • PRESENTED WITH PRIMARY AMENORRHOEA • ASSOCIATED URINARY TRACT ANAMOLIES LIKE RENAL AGENESIS, HORSE SHOE KIDNEY AND PELVIC KIDNEY CAN OCCUR.
  • 50. 4 EVALUATION OF NEWBORN WITH AMBIGUOUS GENITALIA
  • 56. HISTORY • FULL NEWBORN HISTORY (PRENATAL, PREGNANCY AND BIRTH HISTORIES) • ANY MATERNAL VIRILIZATION DURING THE PREGNANCY: ACNE, HIRSUTISM, FRONTAL BALDING, VOICE DEEPENING OR CLITOROMEGALY • MATERNAL HORMONAL DISORDERS • PRENATAL DRUG USE • CONSANGUINITY • DETAILED FAMILY HISTORY LIKE ANY UNEXPLAINED NEONATAL DEATH, AMBIGUOUS GENITALIA, ABNORMAL PUBERTY, INFERTILITY OR AMENORRHEA
  • 57. PHYSICAL EXAMINATION • VITALS (INCLUDING BLOOD PRESSURE), WEIGHT, LENGTH, HEAD CIRCUMFERENCE • INSPECT FOR DEVELOPMENTAL ABNORMALITIES CONSISTENT WITH A POSSIBLE SYNDROME • INSPECT FOR SKIN TURGOR AND HYPERPIGMENTATION • DOCUMENT THE NUMBER AND LOCATION OF UROGENITAL OPENINGS • PALPATE LABIOSCROTAL FOLDS AND INGUINAL REGION FOR GONADS • INSPECT LABIOSCROTAL FOLDS FOR ASYMMETRY, MASCULINIZATION, SWELLING, PIGMENTATION, FUSION AND CREASES • INSPECT PENIS FOR HYPOSPADIAS, URETHRAL DEFECTS, OR CHORDEE • MEASURE PHALLIC LENGTH; MEASURE CLITORAL LENGTH
  • 61. NVESTIGATIONS • KARYOTYPING AND RAPID ANEUPLOIDY TEST • USG ABDOMEN AND PELVIS WITH INGUINAL REGION • SERUM 17-HYDROXYPROGESTERONE LEVEL • SERUM SODIUM, POTASSIUM, RENIN LEVELS • SERUM AMH, TESTOSTERONE, LH, FSH, CORTISOL LEVELS
  • 62. TREATMENT • INVOLVES MULTIDISCIPLINARY TEAM OF ENDOCRINOLOGIST, PEDIATRICIAN, UROLOGIST, GYNECOLOGIST, PSYCHOLOGIST • DEPENDS MAINLY ON THE DIAGNOSIS • 3 MOST COMMONLY FOUND DIAGNOSES ARE CAH,MIXED GONADAL DYSGENESIS, ANDROGEN INSENSITIVITY SYNDROME.
  • 63. TRRATMENT OF CAH • IN SALT WASTING 21-HYDROXYLASE DEFECIENCY CAH START WITH HYDROCORTISONE, FLUDROCORTISONE • PRENATAL DEXAMETHASONE TO MOTHER F/B CHORIONIC VILLLOUS SAMPLING TO DETERMINE SEX AT 12-14 WEEEKS ADVISED IN CARRIERS OR H/O CAH IN MOTHER.
  • 66. • FEMINISING GENITOPLASTY • MASCULINISING GENITOPLASTY • LAPAROSCOPY
  • 67. FEMINISING GENITOPLASTY • CREATION OF FEMALE LOOKING LABIA MAJORA, MINORA WITH INTROITUS • INVERTED V-Y VAGINOPLASTY F/B VAGINAL DILATATIONS TO PROVIDE ADEQUATE FUNCTIONAL VAGINA OPENING INTO INTROITUS • REDUCTION CLITOROPLASTY WITH REDUCTION OF ERECTILE TISSUE i.e. REDUCTION OF PHALLUS WITH PRESERVATION OF GLANS AND ITS NEUROVASCULAR SUPPLY WITH CLITORAL HOOD
  • 68. MASCULINISING GENITOPLASTY • REPAIR HYPOSPADIAS WITH CORRECTION OF CHORDEE • ORCHIDOPEXY • SCROTAL TRANSPOSITION i.e. CORRECT BIFID SCROTUM AND PREPENILE POSITION OF SCROTUM • SEPARATE MULLERIAN STRUCTURES FROM URETHRA • EXCISE IF ANY GONADAL TISSUE WHICH IS AT RISK OF MALIGNANCY
  • 69. LAPAROSCOPY • INDICATIONS 1. TO DIAGNOSE INTRAABDOMINAL ANATOMY WHEN IN DOUBT 2. BIOPSY/EXCISION OF DYSPLASTIC GONADS CONTAINING Y CHROMOSOME 3. EXCISION OF INTERNAL GENITALIA IF NOT REQUIRED FOR ASSIGNED GENDER 4. DIGNOSIS OF COMPLEX CLOACAL ANAMOLIES